Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn’t ...

Several retailers and drug manufacturers as well as one distributor were among those companies recently recognized by ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks.

The company has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). On August 22, BIIB and Eisai Co.

Large drug-maker stocks have witnessed a strong run this year, driven by positive pipeline news and regulatory approvals. The ...

Tony Downs was a powerhouse lawyer with an uncanny memory before the memory-robbing disease took hold. Now, he and his wife are hoping Leqembi, a newly approved drug, will help slow his decline.

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company ...